Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blake

Showing results (691-700 of 894) with videos related to

Pageof 90
Sort By:
Histopathology|December 17, 2013
Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistryMartin Köbel, Julia Bak, Björn I Bertelsen, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 15, 2022
Data Set for the Reporting of Carcinomas of the Vagina: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Richard Wing-Cheuk Wong, Fleur Webster, Tjalling Bosse, et al.
American Journal of Obstetrics and Gynecology|January 14, 2014
Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer preventionJessica N McAlpine, Gillian E Hanley, Michelle M M Woo, et al.
Toxics|July 25, 2025
Subchronic Toxicities of Four Per- and Polyfluoroalkyl Substances (PFASs) by Oral Exposure in Sprague-Dawley RatsElaina M Kenyon, Michael J Devito, Grace Patlewicz, et al.
BMC Cancer|December 17, 2009
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapyJessica N McAlpine, Kimberly C Wiegand, Russell Vang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 13, 2022
Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinomaEmily F Thompson, Kathryn Shum, Richard W C Wong, et al.
Histopathology|April 23, 2016
Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumoursLien N Hoang, Yow-Shan Lee, Anthony N Karnezis, et al.
Gynecologic Oncology|April 14, 2016
Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) studyMartin Köbel, Eshetu G Atenafu, Peter F Rambau, et al.
Histopathology|July 13, 2016
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptorKarama Asleh-Aburaya, Brandon S Sheffield, Zuzana Kos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
Pageof 90

Showing results (691-700 of 894) with videos related to

Sort By:
Pageof 90
Histopathology|December 17, 2013
Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistryMartin Köbel, Julia Bak, Björn I Bertelsen, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 15, 2022
Data Set for the Reporting of Carcinomas of the Vagina: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Richard Wing-Cheuk Wong, Fleur Webster, Tjalling Bosse, et al.
American Journal of Obstetrics and Gynecology|January 14, 2014
Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer preventionJessica N McAlpine, Gillian E Hanley, Michelle M M Woo, et al.
Toxics|July 25, 2025
Subchronic Toxicities of Four Per- and Polyfluoroalkyl Substances (PFASs) by Oral Exposure in Sprague-Dawley RatsElaina M Kenyon, Michael J Devito, Grace Patlewicz, et al.
BMC Cancer|December 17, 2009
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapyJessica N McAlpine, Kimberly C Wiegand, Russell Vang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 13, 2022
Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinomaEmily F Thompson, Kathryn Shum, Richard W C Wong, et al.
Histopathology|April 23, 2016
Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumoursLien N Hoang, Yow-Shan Lee, Anthony N Karnezis, et al.
Gynecologic Oncology|April 14, 2016
Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) studyMartin Köbel, Eshetu G Atenafu, Peter F Rambau, et al.
Histopathology|July 13, 2016
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptorKarama Asleh-Aburaya, Brandon S Sheffield, Zuzana Kos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
Pageof 90